ID   HMDH_RAT                Reviewed;         887 AA.
AC   P51639; Q64601; Q6P2A6;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   31-OCT-2006, sequence version 2.
DT   02-OCT-2024, entry version 193.
DE   RecName: Full=3-hydroxy-3-methylglutaryl-coenzyme A reductase;
DE            Short=HMG-CoA reductase;
DE            EC=1.1.1.34 {ECO:0000269|PubMed:4019513};
GN   Name=Hmgcr;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Hangjiong C., Williams D., Shapiro D.;
RT   "Cloning and sequencing of rat 3-hydroxy-3-methylglutaryl coenzyme A
RT   reductase.";
RL   Submitted (AUG-1994) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 644-887.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RA   Khan S., Kabat S., Stambrook P.;
RT   "Rat HMG-CoA reductase cDNA sequence contains an unusual 36 bp insert
RT   bounded by inverted repeats.";
RL   Submitted (OCT-1990) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   PROTEIN SEQUENCE OF 423-443 AND 867-878, AND PHOSPHORYLATION AT SER-871.
RC   TISSUE=Liver;
RX   PubMed=2369897; DOI=10.1002/j.1460-2075.1990.tb07420.x;
RA   Clarke P.R., Hardie D.G.;
RT   "Regulation of HMG-CoA reductase: identification of the site phosphorylated
RT   by the AMP-activated protein kinase in vitro and in intact rat liver.";
RL   EMBO J. 9:2439-2446(1990).
RN   [5]
RP   CATALYTIC ACTIVITY, FUNCTION, AND SUBUNIT.
RC   TISSUE=Liver;
RX   PubMed=4019513; DOI=10.1016/s0021-9258(17)39243-8;
RA   Edwards P.A., Kempner E.S., Lan S.-F., Erickson S.K.;
RT   "Functional size of rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A
RT   reductase as determined by radiation inactivation.";
RL   J. Biol. Chem. 260:10278-10282(1985).
RN   [6]
RP   PHOSPHORYLATION AT SER-871.
RC   TISSUE=Liver;
RX   PubMed=1628744; DOI=10.1016/0014-5793(92)80837-7;
RA   Gillespie J.G., Hardie D.G.;
RT   "Phosphorylation and inactivation of HMG-CoA reductase at the AMP-activated
RT   protein kinase site in response to fructose treatment of isolated rat
RT   hepatocytes.";
RL   FEBS Lett. 306:59-62(1992).
CC   -!- FUNCTION: Catalyzes the conversion of (3S)-hydroxy-3-methylglutaryl-CoA
CC       (HMG-CoA) to mevalonic acid, the rate-limiting step in the synthesis of
CC       cholesterol and other isoprenoids, thus plays a critical role in
CC       cellular cholesterol homeostasis. {ECO:0000269|PubMed:4019513}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-mevalonate + CoA + 2 NADP(+) = (3S)-hydroxy-3-
CC         methylglutaryl-CoA + 2 H(+) + 2 NADPH; Xref=Rhea:RHEA:15989,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:36464, ChEBI:CHEBI:43074,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.34;
CC         Evidence={ECO:0000269|PubMed:4019513};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:15991;
CC         Evidence={ECO:0000305|PubMed:4019513};
CC   -!- ACTIVITY REGULATION: Regulated by a negative feedback mechanism through
CC       sterols and non-sterol metabolites derived from mevalonate (By
CC       similarity). Phosphorylation at Ser-871 down-regulates the catalytic
CC       activity (By similarity). {ECO:0000250|UniProtKB:P00347,
CC       ECO:0000250|UniProtKB:P04035}.
CC   -!- PATHWAY: Metabolic intermediate biosynthesis; (R)-mevalonate
CC       biosynthesis; (R)-mevalonate from acetyl-CoA: step 3/3.
CC   -!- SUBUNIT: Homotetramer (By similarity). Homodimer (PubMed:4019513).
CC       Interacts (via its SSD) with INSIG1; the interaction, accelerated by
CC       sterols, leads to the recruitment of HMGCR to AMFR/gp78 for its
CC       ubiquitination by the sterol-mediated ERAD pathway. Interacts with
CC       UBIAD1 (By similarity). {ECO:0000250|UniProtKB:P04035,
CC       ECO:0000269|PubMed:4019513}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:P04035}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P00347}. Peroxisome membrane
CC       {ECO:0000250|UniProtKB:P04035}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P00347}.
CC   -!- PTM: Undergoes sterol-mediated ubiquitination and ER-associated
CC       degradation (ERAD). Accumulation of sterols in the endoplasmic
CC       reticulum (ER) membrane, triggers binding of the reductase to the ER
CC       membrane protein INSIG1 or INSIG2. The INSIG1 binding leads to the
CC       recruitment of the ubiquitin ligase, AMFR/gp78, RNF139 or RNF145,
CC       initiating ubiquitination of the reductase. The ubiquitinated reductase
CC       is then extracted from the ER membrane and delivered to cytosolic 26S
CC       proteosomes by a mechanism probably mediated by the ATPase Valosin-
CC       containing protein VCP/p97. The INSIG2-binding leads to the recruitment
CC       of the ubiquitin ligase RNF139, initiating ubiquitination of the
CC       reductase. Lys-248 is the main site of ubiquitination. Ubiquitination
CC       is enhanced by the presence of a geranylgeranylated protein.
CC       {ECO:0000250|UniProtKB:P04035}.
CC   -!- PTM: N-glycosylated. Deglycosylated by NGLY1 on release from the
CC       endoplasmic reticulum (ER) in a sterol-mediated manner.
CC       {ECO:0000250|UniProtKB:P04035}.
CC   -!- PTM: Phosphorylated. Phosphorylation at Ser-871 reduces the catalytic
CC       activity. {ECO:0000250|UniProtKB:P00347}.
CC   -!- SIMILARITY: Belongs to the HMG-CoA reductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M29249; AAA40608.1; -; Genomic_DNA.
DR   EMBL; BC064654; AAH64654.1; -; mRNA.
DR   EMBL; X55286; CAA39001.1; -; mRNA.
DR   PIR; S33175; S33175.
DR   RefSeq; NP_037266.2; NM_013134.2.
DR   AlphaFoldDB; P51639; -.
DR   SMR; P51639; -.
DR   BioGRID; 247704; 1.
DR   MINT; P51639; -.
DR   STRING; 10116.ENSRNOP00000022055; -.
DR   BindingDB; P51639; -.
DR   ChEMBL; CHEMBL3247; -.
DR   DrugCentral; P51639; -.
DR   GuidetoPHARMACOLOGY; 639; -.
DR   GlyCosmos; P51639; 1 site, No reported glycans.
DR   GlyGen; P51639; 1 site.
DR   iPTMnet; P51639; -.
DR   PhosphoSitePlus; P51639; -.
DR   jPOST; P51639; -.
DR   PaxDb; 10116-ENSRNOP00000022055; -.
DR   GeneID; 25675; -.
DR   KEGG; rno:25675; -.
DR   AGR; RGD:2803; -.
DR   CTD; 3156; -.
DR   RGD; 2803; Hmgcr.
DR   VEuPathDB; HostDB:ENSRNOG00000016122; -.
DR   eggNOG; KOG2480; Eukaryota.
DR   HOGENOM; CLU_001734_0_1_1; -.
DR   InParanoid; P51639; -.
DR   OrthoDB; 816560at2759; -.
DR   PhylomeDB; P51639; -.
DR   TreeFam; TF105362; -.
DR   BRENDA; 1.1.1.34; 5301.
DR   Reactome; R-RNO-191273; Cholesterol biosynthesis.
DR   UniPathway; UPA00058; UER00103.
DR   PRO; PR:P51639; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000016122; Expressed in duodenum and 20 other cell types or tissues.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0005778; C:peroxisomal membrane; ISS:UniProtKB.
DR   GO; GO:0120225; F:coenzyme A binding; ISO:RGD.
DR   GO; GO:0030695; F:GTPase regulator activity; ISO:RGD.
DR   GO; GO:0004420; F:hydroxymethylglutaryl-CoA reductase (NADPH) activity; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0070402; F:NADPH binding; ISO:RGD.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IPI:RGD.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; ISO:RGD.
DR   GO; GO:0042632; P:cholesterol homeostasis; IEP:RGD.
DR   GO; GO:0015936; P:coenzyme A metabolic process; IEA:InterPro.
DR   GO; GO:0008299; P:isoprenoid biosynthetic process; IBA:GO_Central.
DR   GO; GO:0060291; P:long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0045445; P:myoblast differentiation; IEP:RGD.
DR   GO; GO:1900222; P:negative regulation of amyloid-beta clearance; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0061179; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:RGD.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; ISO:RGD.
DR   GO; GO:0050709; P:negative regulation of protein secretion; ISO:RGD.
DR   GO; GO:0010664; P:negative regulation of striated muscle cell apoptotic process; IMP:RGD.
DR   GO; GO:0010666; P:positive regulation of cardiac muscle cell apoptotic process; IMP:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:RGD.
DR   GO; GO:0048643; P:positive regulation of skeletal muscle tissue development; IMP:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0032874; P:positive regulation of stress-activated MAPK cascade; IMP:RGD.
DR   GO; GO:0045907; P:positive regulation of vasoconstriction; IMP:RGD.
DR   GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0070723; P:response to cholesterol; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0016126; P:sterol biosynthetic process; IBA:GO_Central.
DR   GO; GO:0070328; P:triglyceride homeostasis; IEP:RGD.
DR   GO; GO:0006743; P:ubiquinone metabolic process; IMP:RGD.
DR   GO; GO:0008542; P:visual learning; ISO:RGD.
DR   CDD; cd00643; HMG-CoA_reductase_classI; 1.
DR   Gene3D; 1.10.3270.10; HMGR, N-terminal domain; 1.
DR   Gene3D; 3.30.70.420; Hydroxymethylglutaryl-CoA reductase, class I/II, NAD/NADP-binding domain; 1.
DR   InterPro; IPR002202; HMG_CoA_Rdtase.
DR   InterPro; IPR023074; HMG_CoA_Rdtase_cat_sf.
DR   InterPro; IPR023076; HMG_CoA_Rdtase_CS.
DR   InterPro; IPR004554; HMG_CoA_Rdtase_eu_arc.
DR   InterPro; IPR004816; HMG_CoA_Rdtase_metazoan.
DR   InterPro; IPR023282; HMG_CoA_Rdtase_N.
DR   InterPro; IPR009023; HMG_CoA_Rdtase_NAD(P)-bd_sf.
DR   InterPro; IPR009029; HMG_CoA_Rdtase_sub-bd_dom_sf.
DR   InterPro; IPR053958; HMGCR/SNAP/NPC1-like_SSD.
DR   InterPro; IPR000731; SSD.
DR   NCBIfam; TIGR00920; 2A060605; 1.
DR   NCBIfam; TIGR00533; HMG_CoA_R_NADP; 1.
DR   PANTHER; PTHR10572; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE; 1.
DR   PANTHER; PTHR10572:SF24; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE; 1.
DR   Pfam; PF00368; HMG-CoA_red; 1.
DR   Pfam; PF12349; Sterol-sensing; 1.
DR   PRINTS; PR00071; HMGCOARDTASE.
DR   SUPFAM; SSF82866; Multidrug efflux transporter AcrB transmembrane domain; 1.
DR   SUPFAM; SSF55035; NAD-binding domain of HMG-CoA reductase; 1.
DR   SUPFAM; SSF56542; Substrate-binding domain of HMG-CoA reductase; 1.
DR   PROSITE; PS00066; HMG_COA_REDUCTASE_1; 1.
DR   PROSITE; PS00318; HMG_COA_REDUCTASE_2; 1.
DR   PROSITE; PS01192; HMG_COA_REDUCTASE_3; 1.
DR   PROSITE; PS50065; HMG_COA_REDUCTASE_4; 1.
DR   PROSITE; PS50156; SSD; 1.
PE   1: Evidence at protein level;
KW   Cholesterol biosynthesis; Cholesterol metabolism;
KW   Direct protein sequencing; Endoplasmic reticulum; Glycoprotein;
KW   Isopeptide bond; Lipid biosynthesis; Lipid metabolism; Membrane; NADP;
KW   Oxidoreductase; Peroxisome; Phosphoprotein; Reference proteome;
KW   Steroid biosynthesis; Steroid metabolism; Sterol biosynthesis;
KW   Sterol metabolism; Transmembrane; Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..887
FT                   /note="3-hydroxy-3-methylglutaryl-coenzyme A reductase"
FT                   /id="PRO_0000114424"
FT   TOPO_DOM        1..9
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TRANSMEM        10..39
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TOPO_DOM        40..56
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TRANSMEM        57..78
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TOPO_DOM        79..89
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TRANSMEM        90..114
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TOPO_DOM        115..123
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TRANSMEM        124..149
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TOPO_DOM        150..159
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TRANSMEM        160..187
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TOPO_DOM        188..191
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TRANSMEM        192..220
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TOPO_DOM        221..248
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TRANSMEM        249..275
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TOPO_DOM        276..314
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TRANSMEM        315..339
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TOPO_DOM        340..887
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   DOMAIN          61..218
FT                   /note="SSD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00199"
FT   MOTIF           75..78
FT                   /note="INSIG-binding motif"
FT                   /evidence="ECO:0000250|UniProtKB:P04035"
FT   ACT_SITE        558
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:P04035"
FT   ACT_SITE        690
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:P04035"
FT   ACT_SITE        766
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:P04035"
FT   ACT_SITE        865
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10003"
FT   MOD_RES         871
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:2369897"
FT   CARBOHYD        281
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CROSSLNK        89
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   CROSSLNK        248
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   CONFLICT        423
FT                   /note="S -> T (in Ref. 4; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        428
FT                   /note="L -> V (in Ref. 4; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        443
FT                   /note="P -> N (in Ref. 4; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        644..653
FT                   /note="IRLQSKTGDA -> PIRSPKRGTS (in Ref. 3; CAA39001)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        673..674
FT                   /note="FF -> GV (in Ref. 1; AAA40608)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        722
FT                   /note="T -> S (in Ref. 3; CAA39001)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        750
FT                   /note="A -> L (in Ref. 1; AAA40608)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        764
FT                   /note="G -> A (in Ref. 3; CAA39001)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   887 AA;  96688 MW;  856D99A9D5FA965C CRC64;
     MLSRLFRMHG LFVASHPWEV IVGTVTLTIC MMSMNMFTGN NKICGWNYEC PKFEEDVLSS
     DIIILTITRC IAILYIYFQF QNLRQLGSKY ILGIAGLFTI FSSFVFSTVV IHFLDKELTG
     LNEALPFFLL LIDLSRASAL AKFALSSNSQ DEVRENIARG MAILGPTFTL DALVECLVIG
     VGTMSGVRQL EIMCCFGCMS VLANYFVFMT FFPACVSLVL ELSRESREGR PIWQLSHFAR
     VLEEEENKPN PVTQRVKMIM SLGLVLVHAH SRWIADPSPQ NSTAEQSKVS LGLAEDVSKR
     IEPSVSLWQF YLSKMISMDI EQVITLSLAL LLAVKYIFFE QAETESTLSL KNPITSPVVT
     PKKAQDNCCR REPLLVRRNQ KLSSVEEDPG VNQDRKVEVI KPLVAEAETS GRATFVLGAS
     AASPPLALGA QEPGIELPSE PRPNEECLQI LESAEKGAKF LSDAEIIQLV NAKHIPAYKL
     ETLMETHERG VSIRRQLLSA KLAEPSSLQY LPYRDYNYSL VMGACCENVI GYMPIPVGVA
     GPLCLDGKEY QVPMATTEGC LVASTNRGCR AISLGGGASS RVLADGMSRG PVVRLPRACD
     SAEVKSWLET PEGFAVVKEA FDSTSRFARL QKLHVTLAGR NLYIRLQSKT GDAMGMNMIS
     KGTEKALLKL QEFFPELQIL AVSGNYCTDK KPAAINWIEG RGKTVVCEAV IPAKVVREVL
     KTTTEAMVDV NINKNLVGSA MAGSIGGYNA HAANIVTAIY IACGQDAAQN VGSSNCITLM
     EASGPTNEDL YISCTMPSIE IGTVGGGTNL LPQQACLQML GVQGACKDNP GENARQLARI
     VCGTVMAGEL SLMAALAAGH LVRSHMVHNR SKINLQDLQG TCTKKAA
//
